Stocks or ETFs side by side: scores, returns, risk, valuation and what they hold.
| Measure | ABBVAbbVie Inc. | AMGNAmgen Inc. |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Drug Manufacturers - General |
| Country | United States | United States |
| Market cap | $519B | $252B |
| Price | $293.89 | $465.23 |
| Last day | +0.20% | +0.00% |
, a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.
ABBV analysis and Q-Scores →Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGN analysis and Q-Scores →Data as of 2026-10-13. Not investment advice.